MedTrace Logo

Pacing of the Atria in Sick Sinus Syndrome Trial Preventive Strategies for Atrial Fibrillation

NCT00161538 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 456

Last updated 2006-10-20

No results posted yet for this study

Summary

The purpose of this study is to determine which of 4 lead positions is most effective for pacemaker patients with Sick Sinus Syndrome in order to avoid development of atrial fibrillation.

Conditions

  • Sick Sinus Syndrome

Interventions

DEVICE

Pacing leads to be implanted according randomization.

DEVICE

Selection 9000 prevent AF an Diagnose AF

Sponsors & Collaborators

  • Vitatron GmbH

    collaborator INDUSTRY

  • Medtronic BRC

    lead INDUSTRY

Principal Investigators

  • Stefan G. Spitzer, MD

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-07-31
Completion
2006-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00161538 on ClinicalTrials.gov